Potential increased tumor-dose delivery with combined 131I-MIBG and 90Y-DOTATOC treatment in neuroendocrine tumors: a theoretic model - Madsen, MT; Bushnell, DL; Juweid, ME (J Nucl Med, 2006)
et al.